Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07490444 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: May 26, 2026 to Jul 13, 2026v3
  2. Recruitment openedv2 Show 4 more changesShow less
    • Start date changed from estimate of Apr 13, 2026 to May 26, 2026
    • Secondary endpoints: details revised at 3 of 4 entries
    • Study description expanded, about 7 words
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study seeks to determine whether glasses prescriptions determined from computer analysis of detailed images of the eyes provide better vision outcomes for children with Down syndrome than prescriptions determined using routine clinical methods.
Trial Details
NCT Number NCT07490444
Lead Sponsor Ohio State University
Collaborators: National Eye Institute (NEI)
Conditions
(from sponsor)		 Refractive Error Correction, Visual Acuity
Related terms Down Syndrome
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov